SUMMARY The distinction between myasthenia gravis and Lambert Eaton myasthenic syndrome can usually be made by the clinical and neurophysiological features. A patient was observed with features which suggested a combination of both disorders. This has been described in few patients before. The importance of electromyography in both distal and proximal limb muscles for a correct diagnosis is demonstrated. Only in proximal nerve stimulation tests was proof found of the existence of both syndromes.
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Myasthenia gravis and Lambert Eaton myasthenic syndrome (LEMS) are both autoimmune diseases with impaired neuromuscular transmission. 1-3 Apart from similarities there are essential differences in pathogenesis and therapy; myasthenia gravis is a postsynaptic disorder at the acetylcholine receptor level, while LEMS is thought to be caused by a presynaptic membrane defect.4 Electromyography is probably essential for making the correct diagnosis as clinical features may not be sufficient to differentiate between the two syndromes. We describe a patient with clinical and neurophysiological features which suggest a combination of both diseases. This has been described in few patients before.5-1 5
Case report (fig, upper part) In 1984 an 80 year old woman visited our clinic with complaints of fluctuating weakness of ocular, bulbar and limb muscles, which had existed for several months. Apart from the weakness which could be provoked by exertion, neurological examination showed no abnormalities. The tendon reflexes were sluggish. There was no post-tetanic poten-tiation on clinical testing. In her serum antibodies against acetylcholine receptors were found and the patient was treated with one anticholinesterase agent (mestinon up to 360 mg/day). After 6 months she became increasingly dyspnoeaic and was admitted to hospital where her vital capacity proved to be only 1000 ml. There was obvious ocular, bulbar and generalised muscle weakness, prominent in pelvic and shoulder girdle. A dry mouth, paraesthesias in the limbs and absent tendon reflexes were noticed. Routine haematological, chemical and serological tests revealed no abnormalities. Antibodies against striated muscle, however, were found in the serum along with thyroid and gastric antibodies. The patient was known to suffer from pernicious anaemia; biopsy specimens from the gastric mucosa showed chronic inflammation without signs of malignancy. Chest radiograph and CT were negative for a possible thymoma. As the tensilon test (10 mg i.v.) clinically still resulted in some improvement of muscle strength, neostigmin (45 mg/day) was added to the mestinon medication. After a few days, signs of a cholinergic overdose developed. Repeated neurophysiological testing revealed abnormal findings which suggested the diagnosis of LEMS (see below). Consequently the patient was treated with corticosteroids (prednisone) up to 60 mg/day, tapering off to a 40 mg alternate day dose. Clinically and neurophysiologically there was marked improvement. The patient was able to eat solid food again, to walk without support, and to take care of herself. At the same time the titre of antibodies against acetylcholine receptors in serum decreased from 42 nmol/l to 2 3 nmol/l. Extensive investigations, including CT scan of the lungs and the abdomen, for possible malignancy were negative.
A neuromuscular transmission disorder 
